Schwabe India contributes to the Ebola homoeopathic project
January 30, 2014
Doctors Zone
Journal (JEBH)
Alpha™- Liv Drops
September 29, 2023
No Comments
Alpha – Liv Drops Due to high demand from the market, for a formulation in drops for the liver, apart from the syrup already available in the market, Schwabe India developed this product. Introduction The liver plays a key role in metabolism. It has anabolic and catabolic, exocrine and endocrine functions. The liver is a blood reservoir, filter and store of different substances (e.g. glycogen, vitamins). It is the site of serum protein (e.g. albumin, prothrombin, fibrinogen) and enzyme synthesis. Metabolic processes (e.g. bilirubin, hormone, carbohydrate and lipid turnover) and the removal of toxic products are important liver functions. 1 Hepatotoxins (e.g. alcohol, tetracycline, acetaminophen, fungal toxins, and anabolic steroids) can cause specific damage to liver cells. Toxic hepatitis may be clinically silent or severe enough to lead to the rapid development of hepatic failure. Clinical features include hepatomegaly, enzyme abnormalities, fever, abdominal pain, anorexia, nausea, vomiting and weight loss. In patients with underlying cirrhosis, manifestations of portal hypertension may predominate. Aversion to fatty food, abdominal discomfort, nausea and vomiting after meals may be symptoms of 2 cholelithiasis. Jaundice results from accumulation of bilirubin. It has non-hepatic as well as hepatic causes. Hyperbilirubinaemia may be due to abnormalities in the 3 formation, transport, metabolism or excretion of bilirubin. TM Alpha -Liv Drops aids recovery and normalisation of liver functions. Severe liver disease needs specialised treatment. Indications: Slow liver functions, fatty liver, and for supportive treatment of hepatocellular jaundice and toxic liver damage.
Awarded Alternative Medicine Brand of the Year 2014 – Schwabe India
Schwabe News Volume 5 | Issue 10-12 | October – December 2014
Schwabe India is awarded Alternative Medicine Brand of the Year 2014
Schwabe India, the Indian arm of Schwabe Group, world’s largest manufacturer of homoeopathic and phyto medicines, has been awarded “Alternative Medicine Brand of the Year”. It was conferred at the India Health & Wellness Summit & Awards 2014 by Dr. Bindeshwar Pathak of Sulabh International, in the August presence of Minister of Ayush Mr. Shripad Naik. It was bestowed to Schwabe India’s consistent and tireless efforts for public awareness through their brand in the field of alternative medicine in India.
India Health & Wellness Summit & Awards 2014, an initiative by HealthyDunia.com, was jointly presented by Hero Cycles and Yes Bank. It was the first summit held in such a grand scale. The summit was attended by who’s who of Health care and wellness industry and chaired by Ayush Minister. It was held at the Hotel Hyatt Regency in New Delhi on 20th December 2014. The auditorium was packed with around 500 wellness and health care partners.
Schwabe products have been available in India since the beginning of 20th century. In fact the first order from India was raised over a century back. The growing Indian market for Schwabe products necessitated to establishment of a manufacturing facility in India with the aim to provide standard quality products at affordable Indian prices. Homoeopaths in India have used and continue to use Schwabe formulations based on their deep faith in the quality of the medicines. A state-of-the-art manufacturing plant was established in Noida, Uttar Pradesh, which started its operations in 1997. The plant, the only one of its kind in the country, deploys the best technological knowhow available in the world today. The company imparts high grade training to its employees in the original German homoeopathic formulations, while respecting the local legal frame work. Under the professional leadership of Mr. Ashish Kumar, Managing Director of Schwabe India, the company is spreading its wings by increasing the market share. Its present growth rate is much higher than other large scale manufacturers.
Recent Advancements in Basic Homeopathic Research – A Report on Two Significant Publication
In a study conducted at the Experimental Farm of the State University of Santa Catarina, Brazil, researchers investigated the impact of homeopathic treatments on piglets during the nursery phase. The study aimed to determine whether homeopathic agents could reduce fighting behavior, improve growth performance, and affect hematological, metabolic, and oxidative variables. The study included 108 weaned piglets divided into four groups: a negative control group receiving only the basal diet, and three groups receiving different homeopathic treatments at varying dosages.
Journal of Evidence Based Homeopathy Volume: 1, Issue: 1, January - June 2023
Comprehensive articles
Agrohomeopathy – A Review
October 3, 2023
Short cases
Unmasking the Intricacies: A Pyogenic Abscess Case Report
October 3, 2023
Lichen Simplex: A Singular Case Study
October 3, 2023
Ranula Unveiled: A Case Report and Management Approach
October 3, 2023
Lichen Simplex: A Singular Case Study
October 3, 2023
A Puzzling Presentation: A Case Report of Jaundice
October 3, 2023
Recent provings and updated materia medica
Acidum Formicum
October 3, 2023
Mygale
October 3, 2023
Thea Chinensis
October 3, 2023
Materia medica on phytohomeopathy
Chrysarobinum
October 3, 2023
Sanguinarinum nitricum
October 3, 2023
Thiosinaminum
October 3, 2023
Mother tincture
Asparagus Officinalis
October 3, 2023
Ginkgo Biloba
October 3, 2023
Rosmarinus Officinalis
October 3, 2023
Product watch
Alpha™- Liv Drops
September 29, 2023
Good Morning™ Constipation Drops
September 29, 2023
Zauber™ Hair Drops
September 29, 2023
Research News
Schwabe News
September 29, 2023
